School of Medicine

Three WashU faculty members have been awarded a $3 million research grant from the National Institute of Mental Health to address economic and structural barriers associated with access and use of an oral medication to prevent HIV infection.

Juliane Bubeck Wardenburg, MD, PhD, at WashU Medicine, brings empathy and compassion to families with children in critical care. She also is working on strategies to prevent staph infections in infants.

People prescribed the popular GLP-1 weight-loss drugs such as Ozempic and Mounjaro may experience benefits such as increased cognitive and behavioral health, according to scientists at WashU Medicine and the Veterans Affairs St. Louis Health Care System. But users may also face increased risks for pancreatitis and kidney conditions, among other illnesses.

A new study led by WashU Medicine researchers has found older-looking brains in adults with sickle cell disease, helping to explain the cognitive challenges experienced by such individuals.

Research from WashU Medicine found a possible new treatment strategy for certain types of blood cancers.

A phase 1 clinical trial co-led by researchers at WashU Medicine found that a new type of cell-based immunotherapy was safe for patients with several types of B-cell lymphoma, a type of blood cancer.

The Internal Medicine Residency Program at WashU Medicine has received the Accreditation Council for Graduate Medical Education 2025 Barbara Ross-Lee, DO Diversity, Equity, and Inclusion Award.

Mice infected with the bacteria that cause tuberculosis (TB) fared better when treated with an experimental compound that modulates immune responses, according to a study led by Christina Stallings, a professor of molecular microbiology at WashU Medicine.

Researchers at Washington University found correlations between types of brain structure and people who try drugs before age 15.

Kory Lavine, MD, PhD, the Alan A. and Edith L. Wolff Professor of Cardiology at WashU Medicine, has received a $600,000 grant from the Additional Ventures Foundation — an organization that funds research into congenital heart disease — to study hypoplastic left heart syndrome.